Rituxan (rituximab) - Roche
Eosinophilic Granulomatosis With Polyangiitis Presenting With Rare Neurological Manifestations. (PubMed, Case Rep Neurol Med) - Sep 17, 2026 - "The patient was treated with high-dose corticosteroids and rituximab, resulting in significant clinical and biochemical improvement at 3 months. This case illustrates the coexistence of atypical neurological manifestations of EGPA, including prominent myopathy, length-dependent polyneuropathy, and retrospectively suspected central nervous system vasculitic involvement, emphasizing the importance of early recognition and multidisciplinary management." 
Journal • ANCA Vasculitis • Asthma • Eosinophilia • Eosinophilic Granulomatosis With Polyangiitis • Immunology • Inflammation • Langerhans Cell Histiocytosis • Musculoskeletal Pain • Myositis • Pain • Pulmonary Disease • Rare Diseases • Respiratory Diseases • Rheumatology • Vasculitis
http://www.ncbi.nlm.nih.gov/pubmed/42746215
 
Anne-Marie Lavigne; Valérie Gagnon Bruneau
 
Sep 17, 2026
 
Prev Next